- AMERATUNGA R, Jordan A, Lehnert K, Leung E, et al
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
Antiviral Res. 2024 Apr 25:105894. doi: 10.1016/j.antiviral.2024.105894.
PubMed Abstract available - SUN Y, Wagatsuma K, Saito R, Sato I, et al
Duration of fever in children infected with influenza A(H1N1)pdm09, A(H3N2) or B virus and treated with baloxavir marboxil, oseltamivir, laninamivir, or zanamivir in Japan during the 2012-2013 and 2019-2020 influenza seasons.
Antiviral Res. 2024 Jun 17:105938. doi: 10.1016/j.antiviral.2024.105938.
PubMed Abstract available - LE UNP, Chang YJ, Lu CH, Chen Y, et al
Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants.
Antiviral Res. 2024;227:105920.
PubMed Abstract available - LIANG Y, Xiao W, Peng Y, Zhang S, et al
Development of Nanoparticle Vaccines Utilizing Designed Fc-Binding Homo-oligomers and RBD-Fc of SARS-CoV-2.
Antiviral Res. 2024 May 21:105917. doi: 10.1016/j.antiviral.2024.105917.
PubMed Abstract available - BONNEUX B, Shareef A, Tcherniuk S, Anson B, et al
JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase.
Antiviral Res. 2024;227:105907.
PubMed Abstract available - HUANG J, Wang W, Li H, Bai Y, et al
Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2.
Antiviral Res. 2024;227:105905.
PubMed Abstract available - PANDEY K, Acharya A, Pal D, Jain P, et al
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2.
Antiviral Res. 2024;227:105904.
PubMed Abstract available - SALGADO-BENVINDO C, Tas A, Zevenhoven-Dobbe JC, van der Meer Y, et al
Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: a versatile and practical infection model for antiviral research and beyond.
Antiviral Res. 2024 May 7:105903. doi: 10.1016/j.antiviral.2024.105903.
PubMed Abstract available
Biochemistry (Mosc) - AFRIDONOVA ZE, Toptygina AP, Mikhaylov IS
Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins.
Biochemistry (Mosc). 2024;89:872-882.
PubMed Abstract available - ASTAKHOVA EA, Morozov AA, Vavilova JD, Filatov AV, et al
Antigenic Cartography of SARS-CoV-2.
Biochemistry (Mosc). 2024;89:862-871.
PubMed Abstract available
BMC Pediatr - UPPALA R, Seenoikhao N, Sitthikarnkha P, Niamsanit S, et al
Clinical characteristics and prognostic marker for hospitalization in children with influenza infection in an emergency setting.
BMC Pediatr. 2024;24:399.
PubMed Abstract available
BMJ - MORGAN J
“I wasn’t alone after all”-how modelling vulnerability can support staff wellbeing.
BMJ. 2024;385:q1313.
PubMed - ALKHALDI M
Call to boost the profile of the Middle East and north Africa region in global health.
BMJ. 2024;385:q1272.
PubMed - LIMB M
Election watch: How credible are the main parties’ pledges on the NHS?
BMJ. 2024;385:q1320.
PubMed - OXTOBY K
Why I . . . go adventure sailing.
BMJ. 2024;385:q1292.
PubMed - IRWIN EM
Knock, knock. Who’s there? It’s the senior house officers trying to come back . .
BMJ. 2024;385:q1343.
PubMed - POLKINGHORN A
Thank you for waiting.
BMJ. 2024;385:q1295.
PubMed - FEINMANN J
Analysis reveals global post-covid surge in infectious diseases.
BMJ. 2024;385:q1348.
PubMed - LAUNER J
John Launer: Faces or candlesticks? Why we need continuity in teams.
BMJ. 2024;385:q1323.
PubMed - O’DOWD A
World is woefully unprepared for another pandemic, experts warn.
BMJ. 2024;385:q1355.
PubMed - OLIVER D
David Oliver: Will the actions pledged in Labour’s election manifesto save health and social care?
BMJ. 2024;385:q1326.
PubMed - BUSE K, McKee M
UK political parties pledge to strengthen security-yet ignore health security.
BMJ. 2024;385:q1359.
PubMed - ENRIA L, Dwyer H, Marchant M, Beckmann N, et al
Political dimensions of misinformation, trust, and vaccine confidence in a digital age.
BMJ. 2024;385:e079940.
PubMed - VISWANATH K, Lee EJ, Dryer E
Communication inequalities and incomplete data hinder understanding of how social media affect vaccine uptake.
BMJ. 2024;385:e076478.
PubMed - FEINMANN J
GP who confronted Rishi Sunak received “hundreds” of supportive messages from doctors.
BMJ. 2024;385:q1375.
PubMed - LIMB M
Avoidable mortality in England and Wales remains higher than before pandemic, data show.
BMJ. 2024;385:q1370.
PubMed - NOLAN T
Avian flu virus in raw milk … and other research.
BMJ. 2024;385:q1331.
PubMed - IACOBUCCI G
Junior doctors offer prime minister “final chance” to avoid pre-election strike.
BMJ. 2024;385:q1367.
PubMed
Drug Saf - GORDILLO-MARANON M, Candore G, Hedenmalm K, Browne K, et al
Lessons Learned on Observed-to-Expected Analysis Using Spontaneous Reports During Mass Vaccination.
Drug Saf. 2024;47:607-615.
PubMed Abstract available
J Clin Microbiol - YU S-H, Kim K-J, Lee C-C, Puebla YP, et al
Performance evaluation of the Panbio COVID-19/Flu A&B Panel for detection of SARS-CoV-2, influenza A, and influenza B antigens using mid-turbinate nasal swabs.
J Clin Microbiol. 2024 Jun 18:e0020724. doi: 10.1128/jcm.00207.
PubMed Abstract available
J Infect - HALVORSEN B, Viermyr HK, Ueland T, Sagen EL, et al
IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.
J Infect. 2024 May 6:106176. doi: 10.1016/j.jinf.2024.106176.
PubMed - KIRSEBOM FCM, Stowe J, Lopez Bernal J, Allen A, et al
Effectiveness of Autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study.
J Infect. 2024 May 6:106177. doi: 10.1016/j.jinf.2024.106177.
PubMed Abstract available - AMANO M, Ichikawa Y, Matsumoto S, Higashi-Kuwata N, et al
Neutralization activity of HCWs’ sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination.
J Infect. 2024;89:106179.
PubMed - YANG X, Li X, Qiu S, Liu C, et al
Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: a systematic review and meta-analysis of aggregated participant data.
J Infect. 2024 May 14:106183. doi: 10.1016/j.jinf.2024.106183.
PubMed Abstract available - MOKRANI D, Le Hingrat Q, Thy M, Choquet C, et al
Clinical characteristics and outcomes of respiratory syncytial virus-associated ARF in immunocompetent patients: A seven-year experience at a tertiary hospital in France.
J Infect. 2024;89:106180.
PubMed Abstract available - HAN B, Li XM, Li R, Ning W, et al
Epidemiological Surveillance of Acute Respiratory Infections Based on Targeted Metagenomic Next Generation Sequencing During the Flu Season after COVID-19 Pandemic in Beijing.
J Infect. 2024 May 22:106188. doi: 10.1016/j.jinf.2024.106188.
PubMed - ZHAI K, Dong J, Zeng J, Cheng P, et al
Global Antigenic Landscape and Vaccine Recommendation Strategy for Low Pathogenic Avian Influenza A(H9N2) Viruses.
J Infect. 2024 Jun 18:106199. doi: 10.1016/j.jinf.2024.106199.
PubMed Abstract available
J Virol Methods - MORECCHIATO F, Coppi M, Niccolai C, Antonelli A, et al
Evaluation of different molecular systems for detection and quantification of SARS-CoV-2 RNA from wastewater samples.
J Virol Methods. 2024;328:114956.
PubMed Abstract available
JAMA - HARRIS E
Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
PubMed - HARRIS E
Lower Dose of Mpox Vaccine Was Safe, Effective.
JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
PubMed
Lancet - ZAROCOSTAS J
Mental health in emergencies requires “a major rethink”.
Lancet. 2024;403:2582.
PubMed - AHSAN S
Israel border closure denying health care to Gazans.
Lancet. 2024;403:2581.
PubMed - SAMARASEKERA U
African vaccine manufacturing scheme to boost production.
Lancet. 2024;403:2579-2580.
PubMed - KUNKLER I
Improving future UK pandemic management structure.
Lancet. 2024;403:2592.
PubMed - YOON JH, Kwon IH, Park HW
The South Korean health-care system in crisis.
Lancet. 2024;403:2589.
PubMed - THE LANCET
Taking persistent physical symptoms seriously.
Lancet. 2024;403:2565.
PubMed
N Engl J Med
Are We Prepared for Bird Flu?: ITT Episode 32.
N Engl J Med. 2024;390:e59.
PubMed
PLoS Comput Biol- ROJAS CHAVEZ RA, Fili M, Han C, Rahman SA, et al
Mapping the Evolutionary Space of SARS-CoV-2 Variants to Anticipate Emergence of Subvariants Resistant to COVID-19 Therapeutics.
PLoS Comput Biol. 2024;20:e1012215.
PubMed Abstract available
PLoS One - LIMA HS, Tupinambas U, Guimaraes FG
Estimating time-varying epidemiological parameters and underreporting of Covid-19 cases in Brazil using a mathematical model with fuzzy transitions between epidemic periods.
PLoS One. 2024;19:e0305522.
PubMed Abstract available - KOLIVAND P, Saberian P, Arabloo J, Behzadifar M, et al
Impact of COVID-19 pandemic on road traffic injuries in Iran: An interrupted time-series analysis.
PLoS One. 2024;19:e0305081.
PubMed Abstract available - POTTECHER J, Raffi F, Jandrot-Perrus M, Binay S, et al
Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial.
PLoS One. 2024;19:e0302897.
PubMed Abstract available - GORGELS KMF, Mujakovic S, Stallenberg E, Hackert VH, et al
Implementation and effectiveness of non-pharmaceutical interventions, including mask mandates and ventilation, on SARS-CoV-2 transmission (alpha variant) in primary schools in the Netherlands.
PLoS One. 2024;19:e0305195.
PubMed Abstract available - WANG S, Ren J, Guo X
A high-accuracy lightweight network model for X-ray image diagnosis: A case study of COVID detection.
PLoS One. 2024;19:e0303049.
PubMed Abstract available - LENNOX C, Duncan-Zaleski M, Nasim S, Shirley O, et al
The impact of the COVID-19 pandemic for children in custody: An analysis of inspection reports.
PLoS One. 2024;19:e0304862.
PubMed Abstract available - REED DS, McElroy AK, Barbeau DJ, McMillen CM, et al
No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model.
PLoS One. 2024;19:e0290909.
PubMed Abstract available - ZAIDAN M, Puebla Neira D, Polychronopoulou E, Yong-Fang K, et al
Healthcare utilization 9 months pre- and post- COVID-19 hospitalization among patients discharged alive.
PLoS One. 2024;19:e0303509.
PubMed Abstract available - CHERVO TC, Elkin EP, Nugent JR, Valice E, et al
Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system.
PLoS One. 2024;19:e0303303.
PubMed Abstract available - DONAGHY R, Shinskey J, Tsakiris M
Maternal interoceptive focus is associated with greater reported engagement in mother-infant stroking and rocking.
PLoS One. 2024;19:e0302791.
PubMed Abstract available - SETO E
At freedom’s edge: Belief in free will during the COVID-19 pandemic.
PLoS One. 2024;19:e0303291.
PubMed Abstract available - SANDBERG L, Bostrom AM, Hagstromer M, Lindgren C, et al
Feasibility of the “Preventing functional decline in acutely hospitalized older patients (PREV_FUNC)” study-A three-armed randomized controlled pilot trial.
PLoS One. 2024;19:e0304570.
PubMed Abstract available - ZEBALLOS D, Magno L, Aranha Rossi T, Soares F, et al
Performance of two rapid antigen tests against SARS-CoV-2 in neighborhoods of socioeconomic vulnerability from a middle-income country.
PLoS One. 2024;19:e0298579.
PubMed Abstract available - SHENEAMER AM, Halawi MH, Al-Qahtani MH
A hybrid human recognition framework using machine learning and deep neural networks.
PLoS One. 2024;19:e0300614.
PubMed Abstract available - SCHOULTZ M, Mcgrogan C, Carolan C, Macaden L, et al
Exploring barriers to care home research recruitment during the COVID-19 pandemic: The influence of social media recruitment posts and public sentiment.
PLoS One. 2024;19:e0303609.
PubMed Abstract available - GROVER EN, Buchwald AG, Ghosh D, Carlton EJ, et al
Does behavior mediate the effect of weather on SARS-CoV-2 transmission? evidence from cell-phone data.
PLoS One. 2024;19:e0305323.
PubMed Abstract available - BASA M, De Vries J, McDonagh D, Comiskey C, et al
The impact of COVID-19 on non-communicable disease patients in sub-Saharan African countries: A systematic review.
PLoS One. 2024;19:e0293376.
PubMed Abstract available - CHAMPREDON D, Papst I, Yusuf W
ern: An [Formula: see text] package to estimate the effective reproduction number using clinical and wastewater surveillance data.
PLoS One. 2024;19:e0305550.
PubMed Abstract available
Proc Natl Acad Sci U S A - KIM H, Park HH, Kim HN, Seo D, et al
The TOX-RAGE axis mediates inflammatory activation and lung injury in severe pulmonary infectious diseases.
Proc Natl Acad Sci U S A. 2024;121:e2319322121.
PubMed Abstract available - TORTORICE D, Rappuoli R, Bloom DE
The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic.
Proc Natl Acad Sci U S A. 2024;121:e2321978121.
PubMed Abstract available
Vaccine - CHENG TM, Chen YS, Wei KC, Chang YC, et al
Assessment of the herpes zoster risk among renal transplant recipients administered the influenza vaccine.
Vaccine. 2024 Jun 18:S0264-410X(24)00716-3. doi: 10.1016/j.vaccine.2024.
PubMed Abstract available
Virology - NAVEED A, Yu J, Lawson S, Gao R, et al
Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.
Virology. 2024;597:110138.
PubMed Abstract available
Virus Res - RIVETTI AV JR, Reischak D, de Oliveira CHS, Otaka JNP, et al
Phylodynamics of avian influenza A(H5N1) viruses from outbreaks in Brazil.
Virus Res. 2024;347:199415.
PubMed Abstract available
#Influenza and Other Respiratory Viruses Research #References (by AMEDEO.com, June 22 ’24)
Published by
ETIDIoH 